PHAXIAM Therapeutics S.A. (PHXM) NASDAQ
3.10
-0.17(-5.20%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 20.41M |
| Enterprise Value | 20.85M |
| P/E Ratio | -0.02 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0.76 |
| Price/Book Ratio | 0.02 |
| Enterprise/Revenue | 2.87 |
| Enterprise/EBITDA | -0.17 |
Fiscal Year
| Fiscal Year | December 31, 2023 |
| Most Recent Quarter | December 31, 2023 |
Profitability
| Profit Margin | -17.71 |
| Operating Margin | -17.84 |
Management Effectiveness
| Return On Assets | -0.46 |
| Return On Equity | -0.96 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0.28 |
| Gross Profit | -1.61M |
| EBITDA | -22.93M |
| Net Income | -23.49M |
| Diluted EPS | -4.62 |
Balance Sheet
| Total Cash | 10.47M |
| Total Cash/Share | 2.23 |
| Total Debt | 10.92M |
| Total Debt/Equity | 0.52 |
| Current Ratio | 1.06 |
| Book Value Per Share | 5.46 |
Price History
| 52-Week Change | -62.92 |
| 52-Week High | 13 |
| 52-Week Low | 2.5 |
| Moving Average 50 Days | 3.88 |
| Moving Average 200 Days | 5.17 |
Statistics
| Average Volume | 1,889 |
| Shares Outstanding | 6.4M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | September 20, 2023 |
